news
MISSION Therapeutics appoints Paul Wallace as Chief Business Officer
19 March 2015 | By Victoria White
MISSION Therapeutics announces the appointment of Paul Wallace PhD as Chief Business Officer...
List view / Grid view
Drug Discovery
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
news
First treatment approved under EAMS developed using antibody humanization expertise at UK’s MRC Technology
11 March 2015 | By MRC Technology
New breakthrough immunotherapy (pembrolizumab) launched in the UK for treatment of adults with advanced melanoma...
news
University spin-out gets crowdfunding investment to develop a cure for Parkinson’s Disease
9 March 2015 | By Edinburgh Research and Innovation
University of Edinburgh spin-out company Parkure Ltd has successfully attracted over £75,000 in crowdfunding investment through ShareIn, the technology-focussed crowdfunding firm, to develop a cure for Parkinson’s disease...
news
MRC Technology launches respiratory ‘Call for Targets’
2 March 2015 | By MRC Technology
Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease...
news
Registration is open for the 3rd Annual Discovery Chemistry & Drug Design in Berlin, 8th & 9th June 2015
25 February 2015 | By Oxford Global
Oxford Global are proud to present its 3rd Annual Discovery Chemistry & Drug Design will be on the 8th and 9th of June 2015...
news
Registration is open for the 16th Annual Drug Discovery Summit in Berlin, 8th & 9th June 2015
25 February 2015 | By Oxford Global
Oxford Global are proud to present its 16th Annual Drug Discovery Congress will be on the 8th and 9th of June 2015...
news
Leading dementia charity launches three Drug Discovery Institutes
18 February 2015 | By Alzheimer’s Research UK
Institutes at Universities of Cambridge, Oxford and UCL will form £30m Drug Discovery Alliance...
news
SensiQ Technologies and Inventiva set up a European Center of Excellence in surface plasmon resonance (SPR) technologies
9 February 2015 | By SensiQ Technologies/Inventiva
Based in Dijon, France, the Center will boast a unique offering for drug discovery in Europe, combining Inventiva’s screening platforms and libraries with SensiQ’s instrumentation...
news
First patient enrolled in the New Drugs 4 Bad Bugs (ND4BB) programme
3 February 2015 | By Innovative Medicines Initiative (IMI)
Two years after the start of the Innovative Medicines Initiative (IMI)-funded New Drugs 4 Bad Bugs (ND4BB) programme, the first patient has been enrolled into a Phase 2 trial sponsored by MedImmune, the global biologics research and development arm of AstraZeneca. The trial with MEDI4893 is among mechanically ventilated intubated…
news
Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
12 January 2015 | By Roche
Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer...
news
Oxford Global Conferences received excellent feedback from the 2014 Drug Discovery USA Congress
8 January 2015 | By Oxford Global Conferences
Oxford Global Conferences were proud to present the Drug Discovery USA Congress this October in Boston, USA...
news
Trial finds cancer drug can block key signal in cancer growth and drug resistance
6 January 2015 | By The Institute of Cancer Research
An experimental cancer drug may block an important driver for the survival, growth and spread of cancer cells...
news
Key US patents granted for GPCR-focused drug discovery platform arising from pioneering research and translational expertise at MRC and MRC Technology
17 December 2014 | By MRC Technology
Structure-based drug discovery platform targets challenging GPCRs linked to human disease...
news
ZoBio and Domainex join forces to deliver crucial drug target information to support FORMA therapeutics’ drug discovery programs
10 December 2014 | By ZoBio and Domainex
ZoBio (Leiden, The Netherlands) and Domainex Ltd. (Cambridge, UK) announce a collaboration with FORMA Therapeutics (Watertown, MA, USA) to provide NMR-based structural biology services for a substantial panel of FORMA drug targets...
news
reViral receives over US$1Mn in funding
4 December 2014 | By reViral
Second tranche of Seeding Drug Discovery award from Wellcome Trust Innovations...
